Salivary proteins associated with periodontitis in patients with type 2 diabetes mellitus

International Journal of Molecular Sciences

Volumn 13, Issue 4, 2012, Pages 4642-4654

  Chan, Hang Haw ^a   Rahim, Zubaidah H A ^a   Jessie, Kala ^a   Hashim, Onn H ^a   Taiyeb Ali, Tara B ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

2 DE; Periodontitis; Salivary protein; Type 2 diabetes mellitus

Indexed keywords

ACETONE; ACTIN RELATED PROTEIN 3; ALPHA 1 ANTITRYPSIN; BETA ACTIN; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE VI; COMPLEMENT COMPONENT C3; DITHIOTHREITOL; GLUTATHIONE TRANSFERASE; GLYCEROPHOSPHOINOSITOL INOSITOLPHOSPHODIESTERASE; HAPTOGLOBIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN J; IMMUNOGLOBULIN KAPPA CHAIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LEUKOCYTE ELASTASE INHIBITOR; LIPOCALIN 1; PLASTIN 2; PREALBUMIN; PROTEIN DISULFIDE ISOMERASE; SALIVA PROTEIN; SECRETORY COMPONENT; SEROTRANSFERRIN; TRICHLOROACETIC ACID; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; ANALYTICAL EQUIPMENT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITOMETER; DENSITOMETRY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; HIGH RISK PATIENT; HUMAN; IMAGE ANALYSIS; MALAYSIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIODONTITIS; PRECIPITATION; PREDICTION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SALIVA ANALYSIS; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; VOLUNTEER; CHEMISTRY; COMPLICATION; METABOLISM; SALIVA;

BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; PERIODONTITIS; SALIVA; SALIVARY PROTEINS AND PEPTIDES;

EID: 84860209395     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13044642     Document Type: Article

References (51)

1. Wild, S.H.; Roglic, G.; Green, A.; Sicree, R.; King, H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27, 2569-2569.
2. Loo, J.; Yan, W.; Ramachandran, P.; Wong, D. Comparative human salivary and plasma proteomes. J. Dent. Res. 2010, 89, 1016-1023.
3. The International Diabetes Federation. Diabetes Atlas; The International Diabetes Federation: Brussels, Belgium, 2011. Available online: http://www.idf.org/diabetesatlas/5e/regional-overviews (accessed on 20 December 2011).
4. Ministry of Health. 3rd National Health and Morbidity Survey; Ministry of Health: Putrajaya, Malaysia, 2006.
5. Letchuman, G.; Wan Nazaimoon, W.; Wan Mohamad, W.; Chandran, L.; Tee, G.; Jamaiyah, H.; Isa, M.; Zanariah, H.; Fatanah, I.; Ahmad Faudzi, Y. Prevalence of diabetes in the malaysian national health morbidity survey III 2006. Med. J. Malays. 2010, 65, 173-179.
6. Löe, H. Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care 1993, 16, 329-334.
7. Grossi, S.G. Treatment of periodontal disease and control of diabetes: An assessment of the evidence and need for future research. Ann. Periodontol. 2001, 6, 138-145.
8. Oliver, R.C.; Tervonen, T. Diabetes-A risk factor for periodontitis in adults? J. Periodontol. 1994, 65, 530-538.
9. Tsai, C.; Hayes, C.; Taylor, G.W. Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. Community Dent. Oral Epidemiol. 2002, 30, 182-192.
10. Kingman, A.; Albandar, J.M. Methodological aspects of epidemiological studies of periodontal diseases. Periodontology 2000 2002, 29, 11-30.
11. Kinane, D.; Bouchard, P.; Group E of European Workshop on Periodontology. Periodontal diseases and health: Consensus report of the sixth European workshop on periodontology. J. Clin. Periodontol. 2008, 35, 333-337.
12. Grossi, S.G.; Genco, R.J. Periodontal disease and diabetes mellitus: A two-way relationship. Ann. Periodontol. 1998, 3, 51-61.
13. Oral Health Division, Ministry of Health, Malaysia. National Oral Health Survey of Adults; Ministry of Health: Putrajaya, Malaysia, 2000.
14. Kaufman, E.; Lamster, I.B. The diagnostic applications of saliva-A review. Crit. Rev. Oral Biol. Med. 2002, 13, 197-212.
15. Mandel, I.D. The functions of saliva. J. Dent. Res. 1987, 66, 623-627.
16. Hofman, L.F. Human saliva as a diagnostic specimen. J. Nutr. 2001, 131, 1621S-1625S.
17. Streckfus, C.; Bigler, L. Saliva as a diagnostic fluid. Oral Dis. 2002, 8, 69-76.
18. Wong, D.T. Salivary diagnostics powered by nanotechnologies, proteomics and genomics. J. Am. Dent. Assoc. 2006, 137, 313-321.
19. Helmerhorst, E.; Oppenheim, F. Saliva: A dynamic proteome. J. Dent. Res. 2007, 86, 680-693.
20. Jessie, K.; Hashim, O.H.; Rahim, Z.H.A. Protein precipitation method for salivary proteins and rehydration buffer for two-dimensional electrophoresis. Biotechnology 2008, 7, 686-693.
21. Gonçalves, L.D.R.; Soares, M.R.; Nogueira, F.; Garcia, C.; Camisasca, D.R.; Domont, G.; Feitosa, A.C.R.; Pereira, D.A.; Zingali, R.B.; Alves, G. Comparative proteomic analysis of whole saliva from chronic periodontitis patients. J. Proteomics 2010, 73, 1334-1341.
22. Huang, C.M. Comparative proteomic analysis of human whole saliva. Arch. Oral Biol. 2004, 49, 951-962.
23. Jessie, K.; Pang, W.W.; Rahim, Z.H.A.; Hashim, O.H. Proteomic analysis of whole human saliva detects enhanced expression of interleukin-1 receptor antagonist, thioredoxin and lipocalin-1 in cigarette smokers compared to non-smokers. Int. J. Mol. Sci. 2010, 11, 4488-4505.
24. Rao, P.V.; Reddy, A.P.; Lu, X.; Dasari, S.; Krishnaprasad, A.; Biggs, E.; Roberts, C.T.; Nagalla, S.R. Proteomic identification of salivary biomarkers of type-2 diabetes. J. Proteome Res. 2009, 8, 239-245.
25. Muscari, A.; Antonelli, S.; Bianchi, G.; Cavrini, G.; Dapporto, S.; Ligabue, A.; Ludovico, C.; Magalotti, D.; Poggiopollini, G.; Zoli, M. Serum C3 is a stronger inflammatory marker of insulin resistance than C-reactive protein, leukocyte count, and erythrocyte sedimentation rate. Diabetes Care 2007, 30, 2362-2368.
26. Johansen, F.; Braathen, R.; Brandtzaeg, P. Role of J chain in secretory immunoglobulin formation. Scand. J. Immunol. 2000, 52, 240-248.
27. Max, E.E.; Korsmeyer, S.J. Human J chain gene. Structure and expression in B lymphoid cells. J. Exp. Med. 1985, 161, 832-849.
28. Zikan, J.; Novotny, J.; Trapane, T.L.; Koshland, M.E.; Urry, D.W.; Bennett, J.C.; Mestecky, J. Secondary structure of the immunoglobulin J chain. Proc. Natl. Acad. Sci. USA 1985, 82, 5905-5909.
29. Asano, M.; Komiyama, K. Polymeric immunoglobulin receptor. J. Oral Sci. 2011, 53, 147-156.
30. Bostanci, N.; Heywood, W.; Mills, K.; Parkar, M.; Nibali, L.; Donos, N. Application of label-free absolute quantitative proteomics in human gingival crevicular fluid by LC/MSE (gingival exudatome). J. Proteome Res. 2010, 9, 2191-2199.
31. UniProtKB Plastin-2 P13796 (PLSL_HUMAN). Available online: http://www.uniprot.org/uniprot/P13796 (accessed on 11 July 2011).
32. Jones, S.L.; Wang, J.; Turck, C.W.; Brown, E.J. A role for the actin-bundling protein L-plastin in the regulation of leukocyte integrin function. Proc. Natl. Acad. Sci. USA 1998, 95, 9331-9336.
33. Grant, M.M.; Creese, A.J.; Barr, G.; Ling, M.R.; Scott, A.E.; Matthews, J.B.; Griffiths, H.R.; Cooper, H.J.; Chapple, I.L.C. Proteomic analysis of a noninvasive human model of acute inflammation and its resolution: The twenty-one day gingivitis model. J. Proteome Res. 2010, 9, 4732-4744.
34. UniProtKB Leukocyte elastase inhibitor P30740 (ILEU_HUMAN). Available online: http://www.uniprot.org/uniprot/P30740 (accessed on 11 July 2011).
35. Remold-O'Donnell, E.; Chin, J.; Alberts, M. Sequence and molecular characterization of human monocyte/neutrophil elastase inhibitor. Proc. Natl. Acad. Sci. USA 1992, 89, 5635-5639.
36. Kivelä, J.; Parkkila, S.; Parkkila, A.K.; Leinonen, J.; Rajaniemi, H. Salivary carbonic anhydrase isoenzyme VI. J. Physiol. 1999, 520, 315-320.
37. Jiang, W.; Gupta, D. Structure of the carbonic anhydrase VI (CA6) gene: Evidence for two distinct groups within the alpha-CA gene family. Biochem. J. 1999, 344, 385-390.
38. Karhumaa, P.; Leinonen, J.; Parkkila, S.; Kaunisto, K.; Tapanainen, J.; Rajaniemi, H. The identification of secreted carbonic anhydrase VI as a constitutive glycoprotein of human and rat milk. Proc. Natl. Acad. Sci. USA 2001, 98, 11604-11608.
39. Kivelä, J.; Laine, M.; Parkkila, S.; Rajaniemi, H. Salivary carbonic anhydrase VI and its relation to salivary flow rate and buffer capacity in pregnant and non-pregnant women. Arch. Oral Biol. 2003, 48, 547-551.
40. UniProtKB Actin-related protein 3 P61158 (ARP3_HUMAN). Available online: http://www.uniprot.org/uniprot/P61158 (accessed on 10 July 2011).
41. Dayel, M.J.; Holleran, E.A.; Mullins, R.D. Arp2/3 complex requires hydrolyzable ATP for nucleation of new actin filaments. Proc. Natl. Acad. Sci. USA 2001, 98, 14871-14876.
42. Dayel, M.J.; Mullins, R.D. Activation of Arp2/3 complex: Addition of the first subunit of the new filament by a WASP protein triggers rapid ATP hydrolysis on Arp2. PLoS Biol. 2004, 2, doi:10.1371/journal.pbio.0020091.
43. Aksentijevich, I.; Masters, S.L.; Ferguson, P.J.; Dancey, P.; Frenkel, J.; van Royen-Kerkhoff, A.; Laxer, R.; Tedgård, U.; Cowen, E.W.; Pham, T.H. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N. Engl. J. Med. 2009, 360, 2426-2437.
44. Arend, W.P.; Guthridge, C.J. Biological role of interleukin 1 receptor antagonist isoforms. Ann. Rheum. Dis. 2000, 59, i60-i64.
45. Gabay, C.; Smith, M.; Eidlen, D.; Arend, W.P. Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein. J. Clin. Investig. 1997, 99, 2930-2940.
46. Granowitz, E.V.; Clark, B.; Mancilla, J.; Dinarello, C. Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor. J. Biol. Chem. 1991, 266, 14147-14150.
47. Juge-Aubry, C.E.; Somm, E.; Giusti, V.; Pernin, A.; Chicheportiche, R.; Verdumo, C.; Rohner-Jeanrenaud, F.; Burger, D.; Dayer, J.M.; Meier, C.A. Adipose tissue is a major source of interleukin-1 receptor antagonist. Diabetes 2003, 52, 1104-1110.
48. Larsen, C.M.; Faulenbach, M.; Vaag, A.; Ehses, J.A.; Donath, M.Y.; Mandrup-Poulsen, T. Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes. Diabetes Care 2009, 32, 1663-1668.
49. Larsen, C.M.; Faulenbach, M.; Vaag, A.; Vølund, A.; Ehses, J.A.; Seifert, B.; Mandrup-Poulsen, T.; Donath, M.Y. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med. 2007, 356, 1517-1526.
50. Heukeshoven, J.; Dernick, R. Simplified method for silver staining of proteins in polyacrylamide gels and the mechanism of silver staining. Electrophoresis 1985, 6, 103-112.
51. Benjamini, Y.; Hochberg, Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 1995, 57, 289-300.